共 50 条
- [41] Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis [J]. PROTEIN AND PEPTIDE LETTERS, 2008, 15 (03): : 314 - 317
- [43] Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis? [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (08): : 400 - 401
- [45] Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis? [J]. Nature Clinical Practice Rheumatology, 2006, 2 : 400 - 401
- [46] High Titer IgG Anti-Cyclic Citrullinated Peptide Antibodies Are Associated With Joint Destruction In Juvenile Idiopathic Arthritis Patients [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S936 - S936
- [47] Diagnostic value of synovial fluid anti-cyclic citrullinated peptide antibody for rheumatoid arthritis [J]. Rheumatology International, 2010, 30 : 1465 - 1470
- [48] Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients [J]. Clinical Rheumatology, 2016, 35 : 601 - 607
- [50] Anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis (jia). A monocentric cross-sectional study. [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S84 - S84